ZyVersa Therapeutics Inc.
November 05, 2024 - by Joey Ramson
$ZVSA is leading the Prism MarketView Biotech index after releasing positive data that demonstrates the potential of inflammasome inhibition to protect pancreatic Islet Beta Cells and attenuate progression from obesity to insulin resistance and type 2 diabetes
